Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer
4 competing products in clinical development for Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer.
Pipeline by Phase
Pre-clinical1
Phase 33
All Products (4)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| zolbetuximab + Pembrolizumab + Capecitabine + Oxaliplatin + Folinic acid (leucovorin or local equivalent) + 5-fluorouracil (5-FU) + Placebo | Astellas Pharma | Phase 3 | Recruiting | 47 |
| zolbetuximab + placebo + oxaliplatin + folinic acid + fluorouracil | Astellas Pharma | Phase 3 | Active | 44 |
| zolbetuximab + oxaliplatin + capecitabine + placebo | Astellas Pharma | Phase 3 | Active | 44 |
| zolbetuximab | Astellas Pharma | Pre-clinical | Recruiting | 33 |